What are INDmoney investors doing with Glenmark Pharmaceuticals shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+97%
Searches for Glenmark Pharmaceuticals on INDmoney have increased by 97% over the last 30 days.
Investment activity on INDmoney
+281.15%
Investment activity in Glenmark Pharmaceuticals among INDmoney users has increased by 281.15% over the last 30 days.
Among the most traded stocks
203rd
Glenmark Pharmaceuticals was the 203rd most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
25 days
INDmoney investors hold Glenmark Pharmaceuticals shares for an average of 25 days.
Key Events for Glenmark Pharmaceuticals
Glenmark Pharmaceuticals Stock Performance
as on November 20, 2026 at 9:31 pm IST
Day's Low
Day's High
₹2,601.90₹2,657.70
1.74%
Downside
0.37%
Upside

52 Week's Low
52 Week's High
₹1,818.00₹2,714.00
31.34%
Downside
2.49%
Upside

Glenmark Pharmaceuticals share price movements today
- Previous Close
- ₹2,608.50
- Open
- ₹2,607.90
- Volume
- 5.40L
- Upper Circuit
- ₹2,723.70
- Lower Circuit
- ₹2,565.10
- Day's Low - High
- ₹2,601.90 - ₹2,657.70
- 52 Week Low - High
- ₹1,818.00 - ₹2,714.00
Glenmark Pharmaceuticals Historical Returns
- 1 Month Return
- + 20.45 %
- 3 Month Return
- + 10.76 %
- 1 Year Return
- + 43.73 %
- 3 Year Return
- + 241.13 %
- 5 Year Return
- + 464.3 %
Glenmark Pharmaceuticals Fundamentals
as on November 20, 2026 at 4:01 pm IST
Market Cap
₹74,733.09 Cr
Return on Equity (ROE)
3.87
PE Ratio (TTM)
51.49
Return on capital employed (ROCE)
6.3
Industry PE ratio
54.13
Beta (LTM)
0.91
P/B Ratio
2.49
Dividend Yield
0.23
PEG Ratio
3.29
Quarterly Earnings Growth YOY
-56.78
EPS (TTM)
48.26
Book Value
372.51
Glenmark Pharmaceuticals Stock Valuation
as on November 20, 2026 at 4:01 pm IST
Glenmark Pharmaceuticals in the last 5 years
Lowest (-275.05x)
December 28, 2023
Today (51.49x)
November 20, 2026
Industry (54.13x)
November 20, 2026
Highest (95.94x)
September 14, 2023
Today’s Price to Earnings Ratio: 51.49x
Glenmark Pharmaceuticals Technical Analysis
Track how Glenmark Pharmaceuticals technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | 1.32 | |
CCI (20) | 19.83 | Neutral |
RSI (14) | 59.33 | Neutral |
Momentum (10) | 0 | Neutral |
ADI (14) | 42.61 | Bullish |
Ultimate Oscillator (7,14,28) | 95.82 | Bullish |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 2647.14 | Bullish |
EMA (20) | 2646.75 | Bullish |
VWMA (20) | 2647.51 | Bullish |
SMA (50) | 2643.6 | Bullish |
EMA (50) | 2645.1 | Bullish |
SMA (200) | 2646.29 | Bullish |
EMA (200) | 2642.75 | Bullish |
KAMA (200) | 2644.28 | Bullish |
DEMA (200) | 2647.46 | Bullish |
Glenmark Pharmaceuticals Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Glenmark Pharmaceuticals with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 74,733.09 | 92.86% | 0.61 | 1,361 | 16,982 | |
| HOLD | 17,688.66 | -1.35% | 0.62 | 150 | 2,268 | |
| BUY | 14,895.35 | 11.27% | 0.73 | 397 | 8,279 | |
| NA | 6,171.10 | -4.62% | 0.66 | 1,553 | 1,879 | |
| BUY | 12,794.35 | 35.96% | 0.68 | 281 | 1,703 |
Market expectation of Glenmark Pharmaceuticals Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
75.00%
Buy
25.00%
Hold
0.00%
Sell
Glenmark Pharmaceuticals Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Glenmark Pharmaceuticals Ltd Annual Profit & Loss
Figures in Rupees Crores
Glenmark Pharmaceuticals Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Glenmark Pharmaceuticals
Holdings as of 15 Nov 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Glenmark Pharmaceuticals
Sorted by largest increase in holding, month-over-month.
No buying activity data available right now
Mutual Funds Exiting Glenmark Pharmaceuticals
Sorted by largest decrease in holding, month-over-month.
Fund Name | Value of Holding | Decrease (MoM) | Holding % |
|---|---|---|---|
Invesco India Large&MidCap Fund Direct Plan Growth | ₹311.44 Cr | ₹38.94 Cr (-11.11%) | 2.17% |
Invesco India Mid Cap Fund Direct Plan Growth Option | ₹485.47 Cr | ₹7.16 Cr (-1.45%) | 2.66% |
Glenmark Pharmaceuticals Corporate Actions
View detailed summary of the earnings and dividend history of Glenmark Pharmaceuticals.
Glenmark Pharmaceuticals Ltd Earnings Results
Glenmark Pharmaceuticals Ltd’s net profit fell -56.78% since last year same period to ₹263.78Cr in the Q2 2026-2027. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated -45.38% fall in its net profits since last 3-months.
Read MoreGlenmark Pharmaceuticals Ltd Dividends May,2026
In the quarter ending March 2026, Glenmark Pharmaceuticals Ltd has declared dividend of ₹2.50 per share on 29 May 2026 - translating a dividend yield of 0.09%.
Read More about Dividends
Indices Featuring Glenmark Pharmaceuticals Stock
Check stock indices that include Glenmark Pharmaceuticals.
Insights on Glenmark Pharmaceuticals Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 1 month, GLENMARK stock has moved up by 20.5%
POSITIVE IMPACTRetail Holding Up

Retail Investor have increased holdings from 13.81% to 14.17% in Sep 2026 quarter
POSITIVE IMPACTRevenue Rich

Revenue is up for the last 4 quarters, 3.94K Cr → 4.24K Cr (in ₹), with an average increase of 2.4% per quarter
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 20.89% to 21.51% in Sep 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 134.3% return, outperforming this stock by 90.5%
NO EFFECTPromoter Holding Unchanged

Promoters holdings remained unchanged at 46.65% of holdings in Sep 2026 quarter
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 512.8% return, outperforming this stock by 271.7%
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 2 quarters, 482.92 Cr → 263.78 Cr (in ₹), with an average decrease of 45.4% per quarter
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 16.76% to 15.61% in Sep 2026 quarter
Glenmark Pharmaceuticals Stock Futures & Options Contracts
View the latest movement in Glenmark Pharmaceuticals Futures & Options, including strike prices, expiry dates, and percentage changes.
Glenmark Pharmaceuticals Options
Glenmark Pharmaceuticals Futures
About Glenmark Pharmaceuticals Ltd
Revenue: ₹4,157.09Cr as on September 2026 (Q2 FY27)
Net Profit: ₹263.83Cr as on September 2026 (Q2 FY27)
Listing date: 07 Feb, 2000
Chairperson Name: Glenn Saldanha
| Organisation | Glenmark Pharmaceuticals Ltd |
| Headquarters | Mumbai |
| Industry | Pharmaceuticals |
| CEO | Glenn Saldanha |
| E-voting on shares | Click here to vote |
FAQs
What is Glenmark Pharmaceuticals share price today?
Glenmark Pharmaceuticals share price today stands at ₹2648 as on at the close of the market. Glenmark Pharmaceuticals share today touched a day high of ₹2657.7 and a low of ₹2601.9.
What is the 52 week high and 52 week low range for Glenmark Pharmaceuticals share?
Glenmark Pharmaceuticals touched a 52 week high of ₹2714 and a 52 week low of ₹1818. Glenmark Pharmaceuticals share price today i.e. is closed at ₹2648, which is -2.43% down from its 52 week high and 45.65% up from its 52 week low.
What is Glenmark Pharmaceuticals's market capitalisation today?
Glenmark Pharmaceuticals market capitalisation is ₹74,733.09 Cr as on .
How to buy Glenmark Pharmaceuticals shares?
To buy Glenmark Pharmaceuticals shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for GLENMARK or Glenmark Pharmaceuticals Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Glenmark Pharmaceuticals shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Glenmark Pharmaceuticals trading volume today?
Glenmark Pharmaceuticals trading volume is 5.40L as on . This means that 5.40L shares of Glenmark Pharmaceuticals were bought and sold on the stock market during today's trading session.
What are INDmoney investors doing with Glenmark Pharmaceuticals shares right now?
Based on aggregated, anonymised INDmoney platform data, search interest and investment activity in Glenmark Pharmaceuticals have both increased over the past 30 days, and the average INDmoney investor holds the stock for 25 days. This reflects platform activity only and is not investment advice.